Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2004 by National Taiwan University Hospital.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
National Taiwan University Hospital
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173316
First received: September 12, 2005
Last updated: NA
Last verified: August 2004
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
| Condition |
|---|
|
Oral Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective |
| Official Title: | The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions |
Resource links provided by NLM:
Further study details as provided by National Taiwan University Hospital:
| Estimated Enrollment: | 80 |
| Study Start Date: | August 2004 |
| Estimated Study Completion Date: | June 2005 |
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- oral cancer and oral precancer specimens
Exclusion Criteria:
- other diseases
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00173316
Please refer to this study by its ClinicalTrials.gov identifier: NCT00173316
Contacts
| Contact: Chun-Pin Chiang, DMSc | 886-2-23123456 ext 6855 | cpchiang@ha.mc.ntu.edu.tw |
Locations
| Taiwan | |
| National Taiwan university | Recruiting |
| Taipei, Taiwan, 100 | |
| Principal Investigator: Chun-Pin Chiang, DMSc | |
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
| Principal Investigator: | Chun-Pin Chiang, DMSc | National Taiwan University |
More Information
| ClinicalTrials.gov Identifier: | NCT00173316 History of Changes |
| Other Study ID Numbers: |
9461700614 |
| Study First Received: | September 12, 2005 |
| Last Updated: | September 12, 2005 |
Keywords provided by National Taiwan University Hospital:
|
vascular endothelial growth factor-C VEGF-CR lymphangiogenesis host inflammatory responses |
oral carcinogenesis oral cancers oral premalignant lesions |
Additional relevant MeSH terms:
|
Mouth Neoplasms Lip Neoplasms Carcinogenesis Precancerous Conditions Head and Neck Neoplasms Neoplasms by Site Neoplasms Mouth Diseases |
Stomatognathic Diseases Lip Diseases Neoplastic Processes Pathologic Processes Endothelial Growth Factors Growth Substances Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 24, 2017